Roflumilast for asthma: Efficacy findings in placebo-controlled studies

Pulmonary Pharmacology and Therapeutics

Volumn 35, Issue , 2015, Pages S20-S27

  Meltzer, E O ^a   Chervinsky, P ^b   Busse, W ^c   Ohta, K ^d   Bardin, P ^e   Bredenbroker D ^f   Bateman, E D ^g  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Northeast Medical Research Associates   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d TOKYO NATIONAL HOSPITAL   (Japan)

^e MONASH MEDICAL CENTRE   (Australia)

^f Takeda Pharmaceuticals International GmbH   (Switzerland)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Asthma; Exacerbation; FEV1; Placebo; Roflumilast

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE; ROFLUMILAST; AMINOPYRIDINE DERIVATIVE; BECLOMETASONE; BENZAMIDE DERIVATIVE; CYCLOPROPANE DERIVATIVE; PHOSPHODIESTERASE IV INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPIROMETRY; TREATMENT RESPONSE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMINOPYRIDINES; ASTHMA; BECLOMETHASONE; BENZAMIDES; CHILD; CYCLOPROPANES; DOUBLE-BLIND METHOD; FORCED EXPIRATORY VOLUME; HUMANS; MIDDLE AGED; PHOSPHODIESTERASE 4 INHIBITORS; QUALITY OF LIFE; YOUNG ADULT;

EID: 84964452549     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2015.10.006     Document Type: Article

References (15)

1. Global Strategy for Asthma Management and Prevention Global Initiative for Asthma (GINA) 2014, Available from:. http://www.ginasthma.org/.
2. Bateman E.D., Izquierdo J.L., Harnest U., et al. Efficacy and safety of roflumilast in the treatment of asthma. Ann. Allergy Asthma Immunol. 2006, 96:679-686.
3. Bousquet J., Aubier M., Sastre J., et al. Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. Allergy 2006, 61:72-78.
4. Grootendorst D.C., Gauw S.A., Verhoosel R.M., et al. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax 2007, 62:1081-1087.
5. Calverley P.M., Rabe K.F., Goehring U.M., et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009, 374:685-694.
6. Fabbri L.M., Calverley P.M., Izquierdo-Alonso J.L., et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009, 374:695-703.
7. Rennard S.I., Calverley P.M., Goehring U.M., et al. Reduction of exacerbations by the PDE4 inhibitor roflumilast-the importance of defining different subsets of patients with COPD. Respir. Res. 2011, 12:18.
8. Juniper E.F., Guyatt G.H., Epstein R.S., et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992, 47:76-83.
9. Juniper E.F., O'Byrne P.M., Guyatt G.H., et al. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 1999, 14:902-907.
10. Djukanovic R., Wilson J.W., Britten K.M., et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am. Rev. Respir. Dis. 1992, 145:669-674.
11. Bateman E.D., Boushey H.A., Bousquet J., et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am. J. Respir. Crit. Care Med. 2004, 170:836-844.
12. Hatzelmann A., Morcillo E.J., Lungarella G., et al. The preclinical pharmacology of roflumilast-a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulm. Pharmacol. Ther. 2010, 23:235-256.
13. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008, 8:183-192.
14. Adams N., Lasserson T.J., Cates C.J., et al. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. Cochrane Database Syst. Rev. 2007 Oct 17, (4):CD002310.
15. Szefler S.J., Martin R.J., King T.S., et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J. Allergy Clin. Immunol. 2002, 109:410-418.